Annual Gross Profit
$120.47 M
-$86.44 M-41.78%
31 December 2023
Summary:
Akebia Therapeutics annual gross profit is currently $120.47 million, with the most recent change of -$86.44 million (-41.78%) on 31 December 2023. During the last 3 years, it has risen by +$122.31 million (+6672.50%). AKBA annual gross profit is now -41.78% below its all-time high of $206.92 million, reached on 31 December 2022.AKBA Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$23.27 M
-$3.33 M-12.53%
30 September 2024
Summary:
Akebia Therapeutics quarterly gross profit is currently $23.27 million, with the most recent change of -$3.33 million (-12.53%) on 30 September 2024. Over the past year, it has dropped by -$770.00 thousand (-3.20%). AKBA quarterly gross profit is now -78.41% below its all-time high of $107.77 million, reached on 30 June 2022.AKBA Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$108.40 M
-$770.00 K-0.71%
30 September 2024
Summary:
Akebia Therapeutics TTM gross profit is currently $108.40 million, with the most recent change of -$770.00 thousand (-0.71%) on 30 September 2024. Over the past year, it has dropped by -$33.76 million (-23.75%). AKBA TTM gross profit is now -48.46% below its all-time high of $210.34 million, reached on 30 September 2019.AKBA TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.8% | -3.2% | -23.8% |
| 3 y3 years | +6672.5% | -29.1% | +151.2% |
| 5 y5 years | -39.8% | -56.7% | -48.5% |
AKBA Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -41.8% | +6672.5% | -78.4% | +131.5% | -47.8% | +151.2% |
| 5 y | 5 years | -41.8% | +6672.5% | -78.4% | +127.5% | -48.5% | +341.4% |
| alltime | all time | -41.8% | +6672.5% | -78.4% | +127.5% | -48.5% | +341.4% |
Akebia Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.27 M(-12.5%) | $108.40 M(-0.7%) |
| June 2024 | - | $26.60 M(+26.7%) | $109.17 M(-10.3%) |
| Mar 2024 | - | $21.00 M(-44.0%) | $121.66 M(+1.0%) |
| Dec 2023 | $120.47 M(-41.8%) | $37.53 M(+56.1%) | $120.48 M(-15.3%) |
| Sept 2023 | - | $24.04 M(-38.5%) | $142.16 M(+10.6%) |
| June 2023 | - | $39.09 M(+97.3%) | $128.55 M(-34.8%) |
| Mar 2023 | - | $19.82 M(-66.5%) | $197.22 M(-5.1%) |
| Dec 2022 | $206.92 M(+239.3%) | $59.21 M(+467.5%) | $207.76 M(+31.0%) |
| Sept 2022 | - | $10.43 M(-90.3%) | $158.60 M(-12.4%) |
| June 2022 | - | $107.77 M(+255.0%) | $180.98 M(+145.8%) |
| Mar 2022 | - | $30.36 M(+202.0%) | $73.64 M(+20.8%) |
| Dec 2021 | $60.98 M | $10.05 M(-69.4%) | $60.98 M(+41.3%) |
| Sept 2021 | - | $32.81 M(+7749.8%) | $43.16 M(+7.9%) |
| June 2021 | - | $418.00 K(-97.6%) | $39.99 M(-189.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $17.70 M(-327.9%) | -$44.90 M(+2349.5%) |
| Dec 2020 | -$1.83 M(-101.0%) | -$7.77 M(-126.2%) | -$1.83 M(-104.9%) |
| Sept 2020 | - | $29.64 M(-135.1%) | $37.34 M(-39.2%) |
| June 2020 | - | -$84.47 M(-239.0%) | $61.41 M(-70.6%) |
| Mar 2020 | - | $60.77 M(+93.5%) | $209.02 M(+10.2%) |
| Dec 2019 | $189.66 M(-5.2%) | $31.41 M(-41.5%) | $189.66 M(-9.8%) |
| Sept 2019 | - | $53.71 M(-14.9%) | $210.34 M(+0.3%) |
| June 2019 | - | $63.13 M(+52.5%) | $209.79 M(+7.3%) |
| Mar 2019 | - | $41.41 M(-20.5%) | $195.45 M(-2.3%) |
| Dec 2018 | $199.97 M(+10.3%) | $52.08 M(-2.0%) | $199.97 M(+35.2%) |
| Sept 2018 | - | $53.17 M(+9.0%) | $147.89 M(+56.1%) |
| June 2018 | - | $48.79 M(+6.2%) | $94.72 M(+106.2%) |
| Mar 2018 | - | $45.93 M | $45.93 M |
| Dec 2017 | $181.23 M(>+9900.0%) | - | - |
| Dec 2016 | $1.53 M | - | - |
FAQ
- What is Akebia Therapeutics annual gross profit?
- What is the all time high annual gross profit for Akebia Therapeutics?
- What is Akebia Therapeutics annual gross profit year-on-year change?
- What is Akebia Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly gross profit year-on-year change?
- What is Akebia Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Akebia Therapeutics?
- What is Akebia Therapeutics TTM gross profit year-on-year change?
What is Akebia Therapeutics annual gross profit?
The current annual gross profit of AKBA is $120.47 M
What is the all time high annual gross profit for Akebia Therapeutics?
Akebia Therapeutics all-time high annual gross profit is $206.92 M
What is Akebia Therapeutics annual gross profit year-on-year change?
Over the past year, AKBA annual gross profit has changed by -$86.44 M (-41.78%)
What is Akebia Therapeutics quarterly gross profit?
The current quarterly gross profit of AKBA is $23.27 M
What is the all time high quarterly gross profit for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly gross profit is $107.77 M
What is Akebia Therapeutics quarterly gross profit year-on-year change?
Over the past year, AKBA quarterly gross profit has changed by -$770.00 K (-3.20%)
What is Akebia Therapeutics TTM gross profit?
The current TTM gross profit of AKBA is $108.40 M
What is the all time high TTM gross profit for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM gross profit is $210.34 M
What is Akebia Therapeutics TTM gross profit year-on-year change?
Over the past year, AKBA TTM gross profit has changed by -$33.76 M (-23.75%)